Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

China flag China · Delayed Price · Currency is CNY
4.960
+0.010 (0.20%)
Apr 29, 2026, 3:04 PM CST
-7.98%
Market Cap 7.08B
Revenue (ttm) 7.13B
Net Income (ttm) 250.38M
Shares Out 1.43B
EPS (ttm) 0.17
PE Ratio 28.37
Forward PE n/a
Dividend 0.06 (1.11%)
Ex-Dividend Date Jun 23, 2025
Volume 13,321,200
Average Volume 22,656,791
Open 5.060
Previous Close 4.950
Day's Range 4.930 - 5.060
52-Week Range 4.650 - 6.680
Beta 0.19
RSI 37.10
Earnings Date Apr 3, 2026

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals manufacturing, pharmaceutical distribution, pharmaceutical engineering, biopharmaceuticals, and other businesses in China. It offers vitamin products, such as vitamin C, vitamin B1, vitamin B6, and L-carnitine series; anti- infective products, such as fosfomycin series, azithromycin series, amantadine series, polyalkali hydrochloride, chloramphenicol, and other products; and reproductive system and hormone products comprising carboprost suppositories, carboprost tromet... [Read more]

Sector Healthcare
Founded 1946
Employees 5,727
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000597
Full Company Profile

Financial Performance

In 2025, SHE:000597's revenue was 7.07 billion, a decrease of -5.70% compared to the previous year's 7.50 billion. Earnings were 260.07 million, a decrease of -36.54%.

Financial Statements

News

There is no news available yet.